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Abstract 
Background: Fascioliasis is a zoonotic disease of livestock and human caused by 
Fasciola species. Here in, the results of serological evaluation of fascioliasis in peo-
ple referring to the School of Public Health, Tehran University of Medical Sciences 
during 2008-2014 are presented.  
Methods: Demographic characterizations, symptoms and eosinophil rate were reg-
istered for every patient. Using somatic antigen of Fasciola, ELISA was performed 
and the results were analyzed. Data of questioners were analyzed as well. 
Results: Among 206 applicants, 24.8% were seropositive for fascioliasis, included 
21% female and 28.3% male. Mean range of age of patients was between 13 to 67 
yr. The highest rate of seropositivity was found among 20-30 yr old patients. Most 
of the patients had hypereosinophilia. All patients had history of eating raw vegeta-
bles, or drinking unsafe water. Patients were referring from different provinces of 
Iran, including Gilan, Mazandaran, Tehran, Ardabil, Khuzestan, Lorestan, North 
Khorasan, Kermanshah, Azerbaijan, Fars, Kordestan, Hamedan and Markazi. 
Conclusion: During recent years, variety of provinces in Iran, where patients with 
fascioliasis are referred, has been increased. Patients coming from Gilan and Ma-
zandaran provinces were referred early after the onset of their symptoms. Most 
probably, physicians in Gilan and Mazandaran are more alert on fascioliasis than 
other provinces. Previous wrong diagnosis was more common among patients re-
ferring from other provinces than Gilan and Mazandaran provinces. 
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Introduction 
 
ascioliasis, caused by Fasciola spp., is a 
zoonotic helminthic diseases included 
among the neglected tropical diseases 
by WHO (1). Iran is amongst the MENA 
countries where human fasciolosis is prevalent 
mostly in northern areas and so far, two epi-
demics of high incidence rate have been re-
ported (1-3). The diagnosis of human fasciolo-
sis in Iran mostly is conducted using ELISA, 
which has showed acceptable sensitivity and 
specificity (4). Although parasitological diagno-
sis of the disease is considered the highest rate 
of specificity but the rate of sensitivity is low 
and some obstacles including transit infection, 
released parasite eggs, needing a specific meth-
od etc. are regarded as negative points on this 
method (1, 5). Although parasitological diag-
nostic technique has the highest rate of sensi-
tivity, some obstacles including  scanty of re-
leased parasite ova, spurious or transient infec-
tion, acute and obstructive infections decrease 
the rate of sensitivity of these methods. To 
overcome this problem an ELISA test, using 
somatic antigen, was established and set-up in 
the Laboratory of Serological Diagnosis of 
Helminthic Diseases of  Department of Medi-
cal Parasitology and Mycology, School of Pub-
lic Health, Tehran University of Medical Sci-
ences, Iran. This test was used as a free of 
charge and authentic diagnostic method to ease 
the diagnosis of human fasciolosis throughout 
Iran. Many patients are referred to this labora-
tory, which considered somehow the main cen-
ter for diagnosis of the disease.  
The present report is to sketch a brief report 
of patients referred to this center during differ-
ent times to assist policy makers on monitoring 
the present situation of fasciolosis in Iran. 
 
Materials and Methods  
 
Patients  
Patients referred from different parts of the 
country to this diagnostic center were included 
in present study.  They either were come by 
themselves or were referred by physicians 
from private clinics, health care units or hospi-
tals due to the presence of clinical symptoms 
or eosinophiliain peripheral blood. In this ret-
rospective descriptive study, the medical rec-
ords of patients attended these centers during 
2008 to 2014 were reviewed. Informed con-
sent was taken from each patient. A ques-
tionnaire including information on location, 
diet, vegetable consumption, travelling to 
northern Iran, clinical symptoms etc. was filled 
out for each patient. Young patients or cases 
that were unable to fill out the form were aided 
by guardians. Blood was taken from all patients 
and sera were stored in refrigerator until exam-
ination. All sera were tested using Indirect 
ELISA established already. 
Patients registered positive for fascioliasis 
were identified; among them, any one whose 
clinical characteristics and demographic data 
were completely available was included inthis 
analytical study. There were also some fascio-
liasis infected cases with incomplete infor-
mation; most of them related to patients who 
could not refer to the centers by themselves 
due to long distance, elderliness, hospitalization 
and so on. Therefore, only their serum samples 
were sent to the laboratories for examination. 
These patients were not enrolled in this study.  
 
Antigen preparation  
For antigen preparation, Fasciola infected liv-
ers were prepared from Tehran slaughter-
houses and transferred to the laboratory.After 
isolation of parasites from liver, and washing 
for 5 times with 0.045 mM PBS, they were 
homogenized with electrical homogenizer. 
After homogenization, sonication was carried 
out and centrifuged in 10000 g at 4 °C for 15 
min. The supernatant was kept in refrigerator 
for later usage (4).  
 
ELISA test   
ELISA test was conducted based on previ-
ously reported study with some modifications 
F 
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(4). Briefly, 100 microliters of somatic antigen 
(10 mg/ml) was added to wells of plate sand 
incubated at 37 °C for 2 h then stay overnight 
at 4 °C. Plates were washed 3 times with 
PBS/Tween 20 then 200 microliters of gelatin 
1% was added to wells of platesand incubated 
at 37 °C for two hours. Wells of plates were 
washed with PBS/Tween 20 for three times. 
One hundred microliters of a serum samples 
(diluted1:500) was added to wells coated with 
antigen and incubated at 37 °C for 30 min. 
Plates were washed 5 times with PBS/Tween 
20. Peroxidase-conjugated goat anti-human 
IgG (diluted 1:10000) was added to wells and 
incubated at 37 °C for 30 min. After final 
washing step with PBS/Tween 20, 100 micro-
liters of OPD was added to wells and reaction 
was stopped with adding 50 microliters of 
stopper solution (12.5% H2S04). OD was 
measured at492 nm with ELISA reader.  
 
Statistical analysis  
Statistical analysis was done using SPSS ver-
sion16 (Chicago, IL, USA). Chi square test 
was used for analyzing of data. Cut-off was 
calculated as mean± 3 SD. 
 
Results  
 
Table 1 shows distribution of the patients 
based on the sex, age groups and percent of 
seropositivity in different age groups. Cut-off 
was calculated as 0.36. 
 
Table 1: Age and sex distribution of fascioliasis in patient referring to the School of Public Health, TUMS 
during 2008-2014 
 
 No. of cases 
examined 
No. of positive 
cases 
Percent of infection Total percent of 
infection 
Sex/ Age  
groups (yr) 
 
Female 
 
Male 
 
Female 
 
Male 
 
Female 
 
Male 
 
11-20 14 13 3 1 21.4 7.7 14.8 
21-30 18 25 6 11 33.3 44.0 39.5 
31-40 25 12 3 5 12 41.7 18.9 
41-50 12 13 4 4 33.3 30.8 32.0 
51-60 13 20 4 5 30.8 25.0 27.3 
61-67 14 16 1 2 7.1 12.5 10.0 
Unknown 4 7 0 2 0 28.6 18.2 
Total 100 106 21 30 21 28.3 24.8 
 
  Overall, the rate of seropositivity was 
24.8% for fascioliasis. Of 206 examined cases, 
51.4% were male and 48.5% were female. The 
age of the patients varied from 13- 67 yr. The 
highest positiverate was in age group of 21-30 
yr old. In 51 patients, two patients were 
asymptomatic, 35 patients (68.6%) reported 
liver pain, and 12 patients (23.5%) complained 
of cutaneous symptoms including itching and 
rash. Pulmonary symptoms were recorded in 
13 patients (25.5%) (Table 2).  
 
Table 2: Distribution of patients infected with fascioliasis according to the sex and eosinophilia 
 
Clinical manifestations 
 
Liver 
symptoms 
Pulmonary 
symptoms 
Cutaneous 
symptoms 
Fever 
Sex n (%) n (%) n (%) n (%) 
Female (n=21) 19(90.5) 6(28.6) 6(28.6) 14 (66.7) 
Male (n=30) 16(53.3) 7(23.3) 6(20.0) 2(6.7) 
Total (51) 35 (68.6) 13 (25.5) 12 (23.5) 26 (50.9) 
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Clinical symptoms were not significant be-
tween male and female patients. Determina-
tion of relative eosinophil count could be pos-
sible for patients, all of them showed more or 
less peripheral eosinophilia, ranging from 6% 
to 66%. 32.3% of patients had eosinophilia 
>30% and 67.6% <30%.  
Patients were referred from different prov-
inces of Iran. The highest infection rate was 
seen in patients from Gilan & Mazandaran 
Provinces, northern parts ofthe country 
(37.3%). Nine patients (17.6%) were from 
Tehran, but all of them had the history of 
traveling to north of Iran. The distribution of 
these people according to their place of living 
is illustrated in (Table 3). All patients encom-
passed history of eating raw vegetables, or 
drinking unsafe water. 
 
Table 3: Distribution of patients infected with fascioliasis according to their province of residence 
 
Province No. of case examined No. of positive cases Rate of infection (%) 
Ardabil 7 4 7.9 
Azerbaijan 1 1 2.0 
Esfahan 3 2 3.9 
Fars 1 1 2.0 
Gilan & Mazandaran 65 19 37.3 
Hamadan 2 1 2.0 
Kermanshah 2 2 3.9 
Khorasan 2 2 3.9 
Khuzestan 3 2 3.9 
Kordestan 3 1 2.0 
Lorestan 7 3 5.9 
Markazi 4 1 2.0 
Tehran 77 9 17.6 
Unknown 29 3 5.9 
Total 206 51 100 
 
As for polyparasitoses, 24.8% of patients 
were infected with fasciolosis only, 0.5% with 
fasciolosis and hydatidosis, simultaneously and 
0.1% with fasciolosis and strongyloidiasis.  
 
Discussion 
 
From 2008 to 2014, altogether 206 patients 
suspected for fascioliasis were referred to our 
center. Overall, 24.8% were seropositive using 
ELISA text. Clinical manifestations and para 
clinical tests boosted the accuracy rate of di-
agnosis. Although the gold standards for diag-
nosis of fasciolosis is stool exam but docu-
mented issues attest a low sensitivity (6, 7), 
however many studies conducted so far ap-
prove the outstanding role of ELISA text on 
diagnosing fasciolosis (4, 8-11). 
The situation of human fasciolosis in Iran 
needs permanent monitoring due to especial 
characteristics and Food habitats found there. 
Iran has experienced two large outbreaks of 
human fascioliasis in 1989 and 1999 affected 
more than 15000 infected cases (12-14). How-
ever, recent survey has revealed prevalence of 
0.4% and 1.2% using coprological and sero-
logical methods, respectively, regarded the ar-
ea as hypoendemic. (15). World Health Or-
ganization (WHO) considers Iran among six 
countries known to have serious Problem with 
facioliasis (16). It is worth mentioning that 
some new reports have been put forwarded 
which demands more cautionary measures to 
monitor the disease in different regions (1, 17-
19). 
We noticed the highest infection rate in 20-
30 yr old. In the outbreaks in Gilan and Ker-
manshah the highest number of infected indi-
viduals was seen in the 10-29 year and in 10-
19 year age groups, respectively (15, 18). In 
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Iran, the numbers of infected cases were high-
er in older (> 20 year) age groups during non-
epidemic situations. The pattern of age wise 
prevalence shows that adults are infected 
more than children in Iran (1, 2). 
The present study shows that cases of hu-
man fascioliasis occur in different parts of the 
country and permanent monitoring should be 
done by health authorities and policy makers 
for preventing the occurrence of another out-
break especially in the northern part. Report-
ing of new foci of human fasciolosis from Ya-
suj (17), Kermanshah (18), Lorestan (Un-
published data), verifies this idea.   
During recent years, the number of prov-
inces from which human cases of fascioliasis 
are referred to our center has increased. Pa-
tients coming from Gilan and Mazandaran 
provinces were referred soon after the onset 
of their symptoms because local physicians are 
more alert on fascioliasis than their counter-
parts working in other provinces are. On the 
other hand, most initial wrong diagnosis were 
among those patients referred from provinces 
other than Gilan and Mazandaran  
 
Conclusion 
 
Although combating any parasitological dis-
ease sounds difficult and sometimes impossi-
ble, but fortunately, previous experiences in 
Iran in terms of elimination the helminthic 
diseases attest that we are able to control hu-
man fasciolosis to an ideal extent and this tar-
get is accessible and achievable. 
 
Acknowledgements  
 
The authors declare that there is no conflict 
of interests.  
 
References 
 
1. Rokni MB, Lotfy WM, Ashrafi K,Murrell KD 
(2014). Fasciolosis in the MENA Region. In: 
Neglected Tropical Diseases - Middle East and 
North Africa. Ed(s),  McDowell MA, Rafati S: 
Springer Vienna. 
2. Rokni M (2008). The present status of human 
helminthic diseases in Iran. Ann Trop Med 
Parasitol, 102:283-295. 
3. Mas-Coma S, Bargues MD,Valero MA (2005). 
Fascioliasis and other plant-borne trematode 
zoonoses. Int J Parasitol, 35:1255-1278. 
4. Rokni MB, Massoud J. O'Neill SM, Parkinson 
M, Dalton JP. Diagnosis of human fasciolosis 
in the Gilan province of Northern Iran: 
application of cathepsin L-ELISA. Diag 
Microbiol Infect Dis. 2002;44:175. 
5. Dalton JP. Fasciolosis. 1st ed. CABI Publishing 
Wallingford, UK, Oxon. 1999. 
6. Rokni MB, Aminian B. Evaluation of the 
Enzyme-linked Immuno-electro Transfer Blot 
(EITB) technique using hydatid cyst antigens 
B/5 and total IgG antibodies in laboratory 
diagnosis of human hydatidosis. Pak J Med Sci. 
2006;22:127-131. 
7. Mas-Coma S, Bargues M. Human liver flukes: a 
review. Res Rev Parasitol. 1997; 57:145-218. 
8. Rokni M, Lesan S, Massoud J, Kia E, Gh M. 
Comparative evaluation of Fast enzyme linked 
immunosorbent assay (Fast-ELISA) and 
standard-ELISA for the diagnosis of human 
hydatidosis. Iran J Public Health. 2006; 
35(2):29-32. 
9. Rokni M, Massoud J, Hanilo A. Comparison of 
adult somatic and cysteine proteinase antigens 
of Fasciola gigantica in enzyme linked 
immunosorbent assay for serodiagnosis of 
human fasciolosis. Acta Trop. 2003;88:69-75. 
10. Awad WS, Ibrahim AK, Salib FA. Using 
indirect ELISA to assess different antigens for 
the serodiagnosis of Fasciola gigantica infection in 
cattle, sheep and donkeys. Res Vet Sci. 
2009;86:466-471. 
11. Hillyer GV. Immunodiagnosis of human and 
animal fasciolosis. In: Fasciolosis. Ed(s),  
Dalton JP. Oxon: CABI Publishing, Wallin-
gford, UK, 1998; p. 435-48. 
12. Massoud J. Fasciolosis outbreak in man and 
drug test (Triclabandazole) in Caspian littoral, 
northern part of Iran. Bull Soc France Parasitol. 
1989; 8:438. 
13. Assmar M, Milaninia A, Amir-Khani A, 
Yadegari D, Forghan-Parast K, Nahravanian H, 
Piazak N, Esmayli A, Hovanesian A,Valadk-
hani Z. Seroepidemiological investigation of 
Aryaeipour et al.: Serological study of Human Fasciolosis in Patients Referring to the School … 
Available at: http://ijpa.tums.ac.ir                                                                                                522 
fascioliasis in northern Iran. Medical Journal of 
the Islamic Republic of Iran. 1991;5:23-27. 
14. Forghan-Parast K,Ashrafi K. Comparison of 
the formalin-ether and Kato-Katz in the 
parasitological diagnosis of human fascioliasis. J 
Med Fac Gilan Univ Med Sci Iran. 2001; 9:1-6. 
15. Ashrafi K, Saadat F, Rahmati B. Evaluating the 
level of endemicity of human fascioliasis in 
rural communities of Bandar-e-Anzali district; 
an important step for implementation of 
disease control programs. First International 
and 8th National Congress of Parasitology and 
Parasitic Diseases in Iran, Kerman, Iran. 2012; 
p. 121. 
16. WHO. (2010) The" Neglected" Neglected 
Worms. Action Against Worms. December 
2007, issue 10.    
17. Sarkari B, Ghobakhloo N, Moshfea A, Eilami 
O. Seroprevalence of human fasciolosis in a 
new-emerging focus of fasciolosis in yasuj 
district, southwest of iran. Iran J Parasitol. 
2012; 7:15-20. 
18. Hatami H, Asmar M, Masoud J, Mansouri F, 
Namdaritabar H, Ramazankhani A. The First 
Epidemic and New-emerging Human 
Fascioliasis in Kermanshah (Western Iran) and 
a Ten-year Follow Up, 1998-2008. Int J Prev 
Med. 2012; 3:266-72. 
19. Rokni MB. Fasciola hepatica and F. gigantica. In: 
Encyclopedia of Food Safety. Ed(s),  
Motarjemi Y: ELSEVIER Publication. 2014. 
 
 
 
 
 
 
  
 
 
